Lola Boutin

Articles

Journal article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2024;54(8):e2350773

Camelid-derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents

Boutin L; Barjon C; Chauvet M; Lafrance L; Senechal E; Bourges D; Vigne E; Scotet E
Journal article: JOURNAL OF CLINICAL INVESTIGATION. 2020;130(9):4637-4651

γ9δ2T cell diversity and the receptor interface with tumor cells.

Vyborova A; Beringer DX; Fasci D; Karaiskaki F; van Diest E; Kramer L; de Haas A; Sanders J; Janssen A; Straetemans T; Olive D; Leusen J; Boutin L; Nedellec S; Schwartz SL; Wester MJ; Lidke KA; Scotet E; Lidke DS; Heck AJ; Sebestyen Z; Kuball J
Journal article: FRONTIERS IN IMMUNOLOGY. 2018;9:828

Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.

Boutin L; Scotet E

Preprint: BIORXIV. 2024

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing

van Bree N; Oppelt A-S; Lindström S; Zhou L; Boutin L; Johnsen JI; Bräutigam L; Wilhelm M
Preprint: BIORXIV. 2023

Targeting human γδ T cells as a potent and safe alternative to pan-T cells bispecific cell engagers

Boutin L; Barjon C; Lafrance L; Senechal E; Bourges D; Vigne E; Scotet E